Atea Pharmaceuticals AVIR
NASDAQ AVIR
$5.26 +0.08 (+1.54%)
As of: Sep 30, 2026 · 10:25 AM EDT

Atea Pharmaceuticals (AVIR) EV to EBIT (2021 - 2022)

Updated

Atea Pharmaceuticals' EV to EBIT came in at -6.28 for Q3 2022, compared with 54.75 a year earlier.

Analysis

Atea Pharmaceuticals (AVIR) EV to EBIT (2021 - 2022) Analysis & Trends

Over the trailing twelve months to Sep 30, 2022, Atea Pharmaceuticals reported EV to EBIT of -77.08; for FY2021, it was -0.15.

  • Business Quant data shows AVIR's EV to EBIT at -3.80 (Q2 2022), -1.59 (Q1 2022) and -0.15 (Q4 2021) in the three quarters before Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Atea Pharmaceuticals 417.06 Mn 417.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -6.28
Jun 30, 2022 -3.80
Mar 31, 2022 -1.59
Dec 31, 2021 -0.15
Sep 30, 2021 54.75
Jun 30, 2021 22.70
Mar 31, 2021 180.62
API Access

Atea Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AVIR&period=max&api_key=YOUR_API_KEY